International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 41 full-time employees. The firm's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. The company is working to launch the RadVent brand of medical devices.
Follow-Up Questions
International Isotopes Inc (INIS)의 PER은 얼마입니까?
International Isotopes Inc의 PER은 3691.183입니다
International Isotopes Inc의 CEO는 누구입니까?
Mr. Shahe Bagerdjian은 2023부터 회사에 합류한 International Isotopes Inc의 President입니다.
INIS 주식의 가격 성능은 어떻습니까?
INIS의 현재 가격은 0.0599이며, 전 거래일에 decreased 0% 하였습니다.
International Isotopes Inc의 주요 사업 주제나 업종은 무엇입니까?
International Isotopes Inc은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
International Isotopes Inc의 시가총액은 얼마입니까?
International Isotopes Inc의 현재 시가총액은 $31.6입니다
International Isotopes Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 0명의 분석가가 International Isotopes Inc에 대한 분석 평가를 실시했으며, 이는 0명의 강력한 매수, 0명의 매수, 0명의 보유, 0명의 매도, 그리고 0명의 강력한 매도를 포함합니다